Josh Welle

Bachelor of Medicine and Bachelor of Science,  CharitĂ© - Universitätsmedizin Berlin 

Location: United States

Consulting Services

Scientific Writing Pharma-CRO-Device Hospital-Pharmacy-Insurance

Areas Of Interest

Wortmannin Culture Medium, Conditioned Skills, Motor Phosphotransferases Brucelloses, Bovine Embryo, Non Mammalian Methylobacterium QDPR Deficiency Initiation Codon Marrubium vulgare Nontuberculous Mycobacterium Infection Seminal Vesicle Proteins Psychodynamic Assessment Carvedilol Endonuclease DdsI alpha Artemether Mesonephric Duct Ectasias, Antral Vascular Intubation Hyperventilation Cell, Interdigitating Stent MAP Kinase Signaling Pathways Aspiration Thrombectomy Vascular Accidents, Brain Thirsts Determination Factors, Left-Right Attachment Sites, Microbiologic Cell Trackings Guanylate Cyclase Activating Protein 1 RNA, Double Stranded c-fos-Induced Growth Factor Hypersensitivity, Tuberculin Type Therapies, Psychoanalytical Hydrogen Chloride Movements, Anti-Vaccine Hygrophila Phenolphthalein Sterol-Regulatory Element-Binding Protein 2 Perforation, Nasal Septal

Professional Narrative

Dr. Josh Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2010
Senior Director, Harvard Med 1993

Education

Master of Science in physician assistant, Yale School of Medicine 2006
Master of Science in physician assistant, Yale School of Medicine 2015

Referees


Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :